Skip to content
White_Message

02/12/2024 – We are currently experiencing issues with our digital ‘contact us’ forms. We appreciate your patience and understanding as we work to resolve this. For urgent matters, please contact us via 0333 103 9499. Alternatively, please email us at generalenquries@sciensus.com with your Full Name, DOB, Postcode and the details of your query.

Eaxpanded Access Programs

Enabling early access to rare and orphan drugs in Europe

Andrew Cummins

By Andrew Cummins

Director of Expanded Access Programs

If you’re considering launching an early access program in the EU, you must be ready. From dealing with multiple regulations to gaining approval, our guide covers essential insights for widening access to your rare drugs.

Download this guide to learn how to navigate the complex European landscape, including takeaways on:

  • The potential challenges
  • What your strategic aims should be
  • Risk and reward
  • A guidance to access and regulation
  • The role of the European Medicines Agency